Home LiteratureArticle Details
PMID: 7813439 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

p53 oligomerization and DNA looping are linked with transcriptional activation.

The EMBO journal ·Vol. 13 ·No. 24 ·1994-12-15 ·Pages 6011-20

Stenger JE, Tegtmeyer P, Mayr GA, Reed M, Wang Y, Wang P, Hough PV, Mastrangelo IA

Abstract

We examined the role of p53 oligomerization in DNA binding and in transactivation. By conventional electron microscopy (EM) and scanning transmission EM, we find that wild-type tetramers contact 18-20 bp at single or tandem 19 bp consensus sequences and also stack in apparent register, tetramer on top of tetramer. Stacked tetramers link separated DNA binding sites with DNA loops. Interestingly, the p53(1-320) segment, which lacks the C-terminal tetramerization domain, binds DNA consensus sites as stacked oligomers. Although the truncated protein binds DNA with reduced efficiency, it nevertheless induces DNA looping by self-association. p53, therefore, has a C-terminal tetramerization domain that enhances DNA binding and a non-tetrameric oligomerization domain that stacks p53 at consensus sites and loops separated consensus sites via protein-protein interactions. Using model promoters, we demonstrate that wild-type and tetramerization-deficient p53s activate transcription well when tandem consensus sites are proximal to TATA sequences and poorly when tandem sites are distal. In the presence of proximal sites, however, stimulation by distal sites increases 25-fold. Tetramerization and stacking of tetramers, therefore, provide dual mechanisms to augment the number of p53 molecules available for activation through p53 response elements. DNA looping between separated response elements further increases the concentration of local p53 by translocating distally bound protein to the promoter.

MeSH Terms
Animals Base Sequence Binding Sites Consensus Sequence DNA/metabolism,ultrastructure Mice Microscopy, Electron, Scanning Transmission Models, Molecular Molecular Sequence Data Molecular Weight Nucleic Acid Conformation Promoter Regions, Genetic Protein Binding Protein Conformation Regulatory Sequences, Nucleic Acid Transcription, Genetic Transcriptional Activation Tumor Suppressor Protein p53/genetics,metabolism,ultrastructure
Chemicals
Tumor Suppressor Protein p53 DNA
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Stenger J E
Department of Molecular Genetics and Microbiology, State University of New York, Stony Brook 11794.
Tegtmeyer P
Mayr G A
Reed M
Wang Y
Wang P
Hough P V
Mastrangelo I A
References (63)
63 references, click to expand
  1. DNA flexibility studied by covalent closure of short fragments into circles.
    Proc Natl Acad Sci U S A. 1981 Aug;78(8):4833-7 PMID: 6272277
  2. ATP-dependent assembly of double hexamers of SV40 T antigen at the viral origin of DNA replication.
    Nature. 1989 Apr 20;338(6217):658-62 PMID: 2539565
  3. Gene regulation by proteins acting nearby and at a distance.
    Nature. 1986 Aug 21-27;322(6081):697-701 PMID: 3018583
  4. Glycogen phosphorylase. The structural basis of the allosteric response and comparison with other allosteric proteins.
    J Biol Chem. 1990 Feb 15;265(5):2409-12 PMID: 2137445
  5. Activators and targets.
    Nature. 1990 Jul 26;346(6282):329-31 PMID: 2142753
  6. Presence of a potent transcription activating sequence in the p53 protein.
    Science. 1990 Aug 31;249(4972):1046-9 PMID: 2144363
  7. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Science. 1990 Aug 31;249(4972):1049-51 PMID: 2144364
  8. Stable DNA loops in vivo and in vitro: roles in gene regulation at a distance and in biophysical characterization of DNA.
    Prog Nucleic Acid Res Mol Biol. 1990;39:81-128 PMID: 2247613
  9. Mutant p53 proteins bind DNA abnormally in vitro.
    Oncogene. 1991 Jan;6(1):131-6 PMID: 1846954
  10. The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops.
    Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3204-8 PMID: 1849647
  11. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription.
    Cell. 1991 May 3;65(3):493-505 PMID: 1850324
  12. DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1.
    Genes Dev. 1991 May;5(5):820-6 PMID: 1851121
  13. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.
    Cell. 1991 Jun 14;65(6):1083-91 PMID: 1646078
  14. Identification of p53 as a sequence-specific DNA-binding protein.
    Science. 1991 Jun 21;252(5013):1708-11 PMID: 2047879
  15. The MCK enhancer contains a p53 responsive element.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4570-1 PMID: 1647009
  16. DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement.
    Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5670-4 PMID: 2062845
  17. p53 mutations in human cancers.
    Science. 1991 Jul 5;253(5015):49-53 PMID: 1905840
  18. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.
    Genes Dev. 1991 Sep;5(9):1646-56 PMID: 1885006
  19. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Nucleic Acids Res. 1991 Oct 11;19(19):5191-8 PMID: 1923804
  20. Wild-type p53 can down-modulate the activity of various promoters.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9979-83 PMID: 1946467
  21. Formation of stable p53 homotetramers and multiples of tetramers.
    Mol Carcinog. 1992;5(2):102-6 PMID: 1554407
  22. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
    EMBO J. 1992 Apr;11(4):1383-90 PMID: 1314165
  23. Mammalian p53 can function as a transcription factor in yeast.
    Nucleic Acids Res. 1992 Apr 11;20(7):1539-45 PMID: 1579447
  24. A transcriptionally active DNA-binding site for human p53 protein complexes.
    Mol Cell Biol. 1992 Jun;12(6):2866-71 PMID: 1588974
  25. Oncogenic forms of p53 inhibit p53-regulated gene expression.
    Science. 1992 May 8;256(5058):827-30 PMID: 1589764
  26. Wild-type p53 activates transcription in vitro.
    Nature. 1992 Jul 2;358(6381):83-6 PMID: 1614538
  27. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element.
    Genes Dev. 1992 Jul;6(7):1143-52 PMID: 1628822
  28. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
    Oncogene. 1992 Aug;7(8):1513-23 PMID: 1321401
  29. p53 function and dysfunction.
    Cell. 1992 Aug 21;70(4):523-6 PMID: 1505019
  30. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.
    Cell. 1992 Nov 13;71(4):587-97 PMID: 1423616
  31. Regulation of the specific DNA binding function of p53.
    Cell. 1992 Nov 27;71(5):875-86 PMID: 1423635
  32. Wild-type p53 binds to the TATA-binding protein and represses transcription.
    Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12028-32 PMID: 1465435
  33. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein.
    J Biol Chem. 1993 Feb 5;268(4):2284-7 PMID: 8428901
  34. Wild-type p53 adopts a 'mutant'-like conformation when bound to DNA.
    EMBO J. 1993 Mar;12(3):1021-8 PMID: 8458320
  35. The p53 protein is an unusually shaped tetramer that binds directly to DNA.
    Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3319-23 PMID: 8475074
  36. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
    Oncogene. 1993 May;8(5):1183-93 PMID: 8479742
  37. Definition of a consensus binding site for p53.
    Nat Genet. 1992 Apr;1(1):45-9 PMID: 1301998
  38. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53.
    Nature. 1993 May 20;363(6426):281-3 PMID: 8387645
  39. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
    Mol Cell Biol. 1993 Jun;13(6):3291-300 PMID: 8497252
  40. p53 domains: suppression, transformation, and transactivation.
    Gene Expr. 1993;3(1):95-107 PMID: 8508031
  41. p53 binds to the TATA-binding protein-TATA complex.
    J Biol Chem. 1993 Jun 25;268(18):13062-7 PMID: 8514746
  42. The p53-mdm-2 autoregulatory feedback loop.
    Genes Dev. 1993 Jul;7(7A):1126-32 PMID: 8319905
  43. Tight DNA binding and oligomerization are dispensable for the ability of p53 to transactivate target genes and suppress transformation.
    EMBO J. 1993 Jul;12(7):2789-97 PMID: 8334995
  44. RIP60 dimers and multiples of dimers assemble link structures at an origin of bidirectional replication in the dihydrofolate reductase amplicon of Chinese hamster ovary cells.
    J Mol Biol. 1993 Aug 5;232(3):766-78 PMID: 8355269
  45. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation.
    Genes Dev. 1993 Oct;7(10):1837-49 PMID: 8405994
  46. Cooperative binding of an Ultrabithorax homeodomain protein to nearby and distant DNA sites.
    Mol Cell Biol. 1993 Nov;13(11):6941-56 PMID: 8105373
  47. Human p53 binds DNA as a protein homodimer but monomeric variants retain full transcription transactivation activity.
    Oncogene. 1993 Nov;8(11):3165-73 PMID: 8414520
  48. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  49. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  50. Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.
    EMBO J. 1993 Dec 15;12(13):5057-64 PMID: 8262048
  51. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Genes Dev. 1993 Dec;7(12B):2556-64 PMID: 8276238
  52. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Genes Dev. 1993 Dec;7(12B):2565-74 PMID: 8276239
  53. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Genes Dev. 1993 Dec;7(12B):2575-86 PMID: 8276240
  54. Analysis of p53 quaternary structure in relation to sequence-specific DNA binding.
    Oncogene. 1994 Jan;9(1):299-303 PMID: 8302593
  55. Sequence-specific transcriptional activation is essential for growth suppression by p53.
    Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):1998-2002 PMID: 8134338
  56. Transcription: in tune with the histones.
    Cell. 1994 Apr 8;77(1):13-6 PMID: 8156588
  57. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.
    Science. 1994 Jul 15;265(5170):346-55 PMID: 8023157
  58. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.
    Science. 1994 Jul 15;265(5170):386-91 PMID: 8023159
  59. The role of activators in assembly of RNA polymerase II transcription complexes.
    Curr Opin Genet Dev. 1994 Apr;4(2):236-44 PMID: 8032201
  60. p53 domains: structure, oligomerization, and transformation.
    Mol Cell Biol. 1994 Aug;14(8):5182-91 PMID: 8035799
  61. Novel subunit-subunit interactions in the structure of glutamine synthetase.
    Nature. 1986 Sep 25-Oct 1;323(6086):304-9 PMID: 2876389
  62. The SV40 enhancer contains two distinct levels of organization.
    Nature. 1988 May 5;333(6168):40-5 PMID: 2834649
  63. DNA-protein complexes spread on N2-discharged carbon film and characterized by molecular weight and its projected distribution.
    J Mol Biol. 1982 Sep 15;160(2):375-86 PMID: 6757448
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1994-12-15
Pages
6011-20
Language
English
Region
England
NLM ID
8208664
PMCID
PMC395578
Subset
IM
Grants
NCI NIH HHS · CA-18808 · United States
NCI NIH HHS · CA-28148 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]